Literature DB >> 11196738

Multiple sclerosis in Northern Ireland: a historical and global perspective.

G V McDonnell1, S A Hawkins.   

Abstract

The uneven worldwide distribution of multiple sclerosis has been of interest to epidemiologists, neurologists and statisticians for over a century, prevalence rates for the disease apparently being determined by variations in age, gender, geography, race and ethnic group. Northern Ireland has been recognised as an area of high MS prevalence since the truly seminal work of Allison and Millar almost 50 years ago. The most recent study in Northern Ireland was undertaken in 1996 and involved the neighbouring districts of Coleraine, Ballymena, Ballymoney and Moyle (population, 151,000). Overall, 254 definite and probable cases were identified (prevalence: 168.2/100,000) with a further 34 suspected cases (overall prevalence: 190.7/100,000). Females predominated (ratio, 2.1:1) and the average age at onset was 31.6 years. The highest age specific prevalence rate for females was in the 35-44 years old age group (519.6/100,000) and for males was in those aged 55-64 (292.3/100,000). The spectrum of disability was broad and 20% could be considered to have relatively "benign" disease. These figures sadly confirm that Northern Ireland has one of the highest and rising MS prevalence rates in the world and implies an enormous potential for societary costs.

Entities:  

Mesh:

Year:  2000        PMID: 11196738      PMCID: PMC2449193     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


  35 in total

1.  High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition.

Authors:  G V McDonnell; S A Hawkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

2.  A prevalence survey of multiple sclerosis in Sussex.

Authors:  M Rice-Oxley; E S Williams; J E Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

3.  Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands.

Authors:  D C Poskanzer; A M Walker; J Yonkondy; J L Sheridan
Journal:  Neurology       Date:  1976-06       Impact factor: 9.910

4.  Prevalence of multiple sclerosis in a south London borough.

Authors:  E S Williams; R O McKeran
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-26

5.  Disability due to multiple sclerosis: a community-based study on an Irish county.

Authors:  M Hutchinson
Journal:  Ir Med J       Date:  1986-02

6.  Declining incidence of multiple sclerosis in the Orkney Islands.

Authors:  S D Cook; J I Cromarty; W Tapp; D Poskanzer; J D Walker; P C Dowling
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

7.  The epidemiology of multiple sclerosis in Queensland, Australia.

Authors:  S R Hammond; C de Wytt; I C Maxwell; P J Landy; D English; J G McLeod; M G McCall
Journal:  J Neurol Sci       Date:  1987-09       Impact factor: 3.181

8.  Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey.

Authors:  G Sharpe; S E Price; A Last; R J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

9.  Multiple sclerosis in the north Cambridgeshire districts of East Anglia.

Authors:  N Robertson; J Deans; M Fraser; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

10.  High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition.

Authors:  P M Rothwell; D Charlton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

View more
  2 in total

1.  The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria.

Authors:  C M Fox; S Bensa; I Bray; J P Zajicek
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

2.  "The Brain Society": The First Two Years of an Undergraduate Neuroscience Society in Northern Ireland.

Authors:  Seong Hoon Lee; Caitlin O'Callaghan; Kah Long Aw; Peter Rogan; Michael Kinney; Stanley Hawkins
Journal:  Ulster Med J       Date:  2020-10-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.